Results 11 to 20 of about 2,770 (170)
Side Effects of Yttrium-90 Radioembolization [PDF]
Frontiers in Oncology, 2014 Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Ahsun eRiaz, Rafia eAwais, Riad eSalem
doaj +3 more sources
Extrahepatic Applications of Yttrium-90 Radioembolization. [PDF]
Semin Intervent Radiol, 2021 AbstractWhile initially described and now accepted as treatment for primary and secondary malignancies in the liver, radioembolization therapy has expanded to include treatment for other disease pathologies and other organ systems. Advantages and limitations for these treatments exist and must be compared against more traditional treatments for these ...
Murali N +4 more
europepmc +3 more sources
Radioembolization for hepatocellular carcinoma: what clinicians need to know [PDF]
Journal of Liver Cancer, 2022 Transarterial radioembolization (TARE) with yttrium 90 (90Y) has been used in the management of hepatocellular carcinoma (HCC) for more than 10 years in Korea.
Jin Woo Choi, Hyo-Cheol Kim
doaj +1 more source
Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis. [PDF]
Korean J Radiol, 2022 Kim HC.
europepmc +4 more sources
PLoS ONE, 2021 BackgroundRecently, the use of Yttrium-90 transarterial radioembolization in non-surgical hepatocellular carcinoma was suggested but the evidence supporting its use is unclear.MethodsWe searched Medline, Embase, Web of Science and Cochrane CENTRAL from ...
Simon Lemieux +6 more
doaj +1 more source
Journal of Interventional Medicine, 2023 Purpose: The IMbrave150 Phase III trial demonstrated the superiority of atezolizumab and bevacizumab (Atezo/Bev) over sorafenib for unresectable hepatocellular carcinoma (HCC).
Qian Yu +8 more
doaj +1 more source
Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports
Einstein (São Paulo), 2020 Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially ...
Vithor de Oliveira Carvalho +9 more
doaj +2 more sources
Single-Compartment Dose Prescriptions for Ablative 90Y-Radioembolization Segmentectomy
Life, 2023 Background: Yttrium-90 (90Y) radioembolization is increasingly being utilized with curative intent. While single-compartment doses with respect to the perfused volume for the complete pathologic necrosis (CPN) of tumors have been reported, the actual ...
Srinivas Cheenu Kappadath +1 more
doaj +1 more source
Frontiers in Oncology, 2014 90Y PET/CT following radioembolization has recently been established as a viable diagnostic tool, capable of producing images that are both quantitative and have superior image quality than alternative 90Y imaging modalities.
Alexander Samuel Pasciak +3 more
doaj +1 more source
Long-Term Palliative Effect of Stenting in Gastric Outlet Obstruction Due to Transarterial Chemoembolization with Yttrium-90 in a Patient with Metastatic Neuroendocrine Tumor [PDF]
Clinical Endoscopy, 2016 Internal radioembolization with yttrium-90 is a promising treatment method, predominantly for liver tumors. However, the shifting of yttrium-90-loaded spherules into the arteries and veins that supply the duodenum and stomach, leading to ulceration ...
Erkan Caglar +3 more
doaj +1 more source